On 12–13 November 2026, Prague will host a meeting of the Consortium and Board of the National Competence Centre project “Personalised Medicine: From Translational Research to Biomedical Applications” (TN02000109), supported by the Technology Agency of the Czech Republic (TA ČR).
The meeting will be hosted by our partner institution, the Institute of Physiology of the Czech Academy of Sciences.
VENUE: Fyziologický ústav AV ČR, Vídeňská 1083,142 00, Prague 4 - Krč
DATE: November 12-13th, 2026
We look forward to meeting our partners and colleagues!
PROGRAM – November 12th
11:30-12:15 LUNCH – buffet (foyer)
KINOSÁL
12:15-12:30 INTRODUCTORY INFORMATION – Vyklický (FGÚ)
12:30-13:00 Hajdúch (DP 14) Management and strategic sub-project, (DP 11) Biomarkers and molecular diagnostics for personalized medicine
13:00-13:30 Kudová/Vyklický (DP 6) - Study of functional and behavioral consequences of disease-associated mutations in the NMDA receptor and potential rescue pharmacology
13:30-14:00 Vrábel/De Sanctis (DP 5) Development of chimeric antigen receptor modified immune cells for cancer immunotherapy
14:00-14:15 BREAK
14:15-14:45 Petřík/Nový (DP 10) Targeted molecular imaging of infection and cancer disorders
14:45-15:15 Tichý (DP 3) Novel nucleoside analogues as potent anticancer drugs
15:15-15:45 Janeba (DP 7) Purine nucleoside phosphorylase inhibitors for treatment of T-cell leukemia
15:45-16:15 Maloy Řezáčová/Brynda (DP4) Theranostic applications of cancer specific carbonic anhydrases
ČÍTÁRNA
13:30-14:30 ADMINISTRATION MEETING (onsite and/or online)
Project/financial managers of consortium
16:30-17:00 BOARD MEETING (onsite and/or online) Decristoforo, Fusek, Hajdúch, Hauser, Martásek, Normanton, Perlík
18:00-20:00 DINNER/NETWORKING – Rezidence Emmy (K Zelené Louce 2a, Praha 4)
PROGRAM – November 13th
KINOSÁL
09:00-9:30 Maletínská (DP 8) Interplay between anorexigenic and orexigenic peptides in Alzheimer’s-like pathology
9:30-10:00 Nencka/Pávek (DP 9) Novel (multi)targeted ligands of nuclear receptors for the therapy of the metabolic diseases
10:00-10:30 Martásek/Mělková (DP 13) Biomedical prospecting of a life pigment: metabolic basis of inherited heme
10:30-10:45 BREAK
10:45-11:15 Prát (DP 12) Casein kinase inhibitors for treatment of human cancers
11:15-11:45 Macek (DP 2) Artificial intelligence, telemedicine and machine learning system for clinical applications
11:45-12:15 Brož (DP 1) Development of informatic solutions enabling digitalization, interpretation and management of human genome data in clinical practice
12:15-13:00 LUNCH – MBÚ AV ČR canteen
